• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估心脏黏液瘤患者栓塞的危险因素:一项系统评价和荟萃分析。

Evaluating risk factors of embolism in patients with cardiac myxoma: A systematic review and meta-analysis.

作者信息

Qureshi Muhammad Ahmad, Bakht Danyal, Ahmed Omair, Haseeb Shahan, Gupta Kartik, Baqal Omar, Amir Maaz, Ali Khawar, Khawar Mirza Muhammad Hadeed, Hussain Muqaddas, Munir Luqman, Othman Hussein

机构信息

Henry Ford Jackson Hospital, Jackson, MI, USA.

King Edward Medical University, Lahore, Punjab, Pakistan.

出版信息

Am Heart J Plus. 2025 May 29;56:100559. doi: 10.1016/j.ahjo.2025.100559. eCollection 2025 Aug.

DOI:10.1016/j.ahjo.2025.100559
PMID:40548199
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12182336/
Abstract

BACKGROUND

Cardiac myxomas (CM), the most common primary cardiac tumors, can cause embolism in about 40 % of cases, making it crucial to identify risk factors for guiding clinical decisions.

OBJECTIVES

In this meta-analysis, we studied the risk factors associated with embolism among patients with cardiac myxomas.

METHODS

A comprehensive search was conducted across PubMed, Embase, and Cochrane Library from their inception until May 2023. Statistical analyses were performed using Cochrane's RevMan 5.4 software. For each risk factor, the pooled odds ratio or mean difference was calculated along with the corresponding 95 % confidence interval.

RESULTS

This meta-analysis incorporated 18 studies with 2601 patients, of whom 525 (20.1 %) experienced embolism. Significant risk factors included hypertension ( = 0.001), NYHA I/II ( = 0.03), irregular tumor surface ( < 0.01), hyperlipidemia (p < 0.01), coronary artery disease ( = 0.01), elevated mean platelet volume ( = 0.02), and high tumor mobility (p < 0.01), while female gender (p = 0.03) was linked to reduced risk. Smoking, atrial fibrillation, tumor size, age, BMI, diabetes, LVEF, and LAD were not significantly associated with embolism ( > 0.05).

CONCLUSION

This analysis is the first to highlight significant pooled outcomes for gender, hyperlipidemia, coronary artery disease, mean platelet volume, and tumor mobility. Patients with these risk factors may benefit from early evaluation and surgery to reduce embolism risk. Statistical analyses were performed using RevMan 5.4, with pooled odds ratios or mean differences calculated alongside 95 % confidence intervals.

摘要

背景

心脏黏液瘤(CM)是最常见的原发性心脏肿瘤,约40%的病例会发生栓塞,因此识别风险因素以指导临床决策至关重要。

目的

在这项荟萃分析中,我们研究了心脏黏液瘤患者发生栓塞的相关风险因素。

方法

从创刊至2023年5月,在PubMed、Embase和Cochrane图书馆进行了全面检索。使用Cochrane的RevMan 5.4软件进行统计分析。对于每个风险因素,计算合并比值比或平均差以及相应的95%置信区间。

结果

这项荟萃分析纳入了18项研究,共2601例患者,其中525例(20.1%)发生了栓塞。显著的风险因素包括高血压(p = 0.001)、纽约心脏协会心功能I/II级(p = 0.03)、肿瘤表面不规则(p < 0.01)、高脂血症(p < 0.01)、冠状动脉疾病(p = 0.01)、平均血小板体积升高(p = 0.02)和肿瘤活动度高(p < 0.01),而女性(p = 0.03)与风险降低有关。吸烟、心房颤动、肿瘤大小、年龄、体重指数、糖尿病、左心室射血分数和左心房内径与栓塞无显著相关性(p > 0.05)。

结论

本分析首次突出了性别、高脂血症、冠状动脉疾病、平均血小板体积和肿瘤活动度的显著合并结果。有这些风险因素的患者可能受益于早期评估和手术,以降低栓塞风险。使用RevMan 5.4进行统计分析,计算合并比值比或平均差以及95%置信区间。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db29/12182336/8504998283be/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db29/12182336/8504998283be/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db29/12182336/8504998283be/gr3.jpg

相似文献

1
Evaluating risk factors of embolism in patients with cardiac myxoma: A systematic review and meta-analysis.评估心脏黏液瘤患者栓塞的危险因素:一项系统评价和荟萃分析。
Am Heart J Plus. 2025 May 29;56:100559. doi: 10.1016/j.ahjo.2025.100559. eCollection 2025 Aug.
2
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
3
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
4
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
Negative pressure wound therapy for surgical wounds healing by primary closure.负压伤口疗法在一期缝合手术伤口愈合中的应用。
Cochrane Database Syst Rev. 2022 Apr 26;4(4):CD009261. doi: 10.1002/14651858.CD009261.pub7.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块型银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2022 May 23;5(5):CD011535. doi: 10.1002/14651858.CD011535.pub5.
8
Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.戒烟药物和电子烟:系统评价、网络荟萃分析和成本效益分析。
Health Technol Assess. 2021 Oct;25(59):1-224. doi: 10.3310/hta25590.
9
Smoking cessation for secondary prevention of cardiovascular disease.戒烟对心血管疾病二级预防的作用。
Cochrane Database Syst Rev. 2022 Aug 8;8(8):CD014936. doi: 10.1002/14651858.CD014936.pub2.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.

本文引用的文献

1
IL-6 at the center of cytokine storm: Circulating inflammation mediators as biomarkers in hospitalized COVID-19 patients.IL-6 处于细胞因子风暴的中心:循环炎症介质作为住院 COVID-19 患者的生物标志物。
J Clin Lab Anal. 2023 Apr;37(7):e24881. doi: 10.1002/jcla.24881. Epub 2023 Apr 25.
2
Risk factors of embolism for the cardiac myxoma patients: a systematic review and metanalysis.心脏黏液瘤患者栓塞风险因素的系统评价和荟萃分析。
BMC Cardiovasc Disord. 2020 Jul 25;20(1):348. doi: 10.1186/s12872-020-01631-w.
3
Mean Platelet Volume (MPV): New Perspectives for an Old Marker in the Course and Prognosis of Inflammatory Conditions.
平均血小板体积(MPV):炎症病程和预后标志物的新视角。
Mediators Inflamm. 2019 Apr 17;2019:9213074. doi: 10.1155/2019/9213074. eCollection 2019.
4
Evaluation of the potential predictors of embolism in patients with left atrial myxoma.左心房黏液瘤患者栓塞潜在预测因素的评估。
Echocardiography. 2019 May;36(5):837-843. doi: 10.1111/echo.14331. Epub 2019 Apr 1.
5
Twenty Years of Clinical Experience with Cardiac Myxomas: Diagnosis, Treatment, and Follow Up.心脏黏液瘤二十年临床经验:诊断、治疗及随访
J Cardiovasc Imaging. 2019 Jan;27(1):37-47. doi: 10.4250/jcvi.2019.27.e7.
6
Echocardiographic Findings and Clinical Correlation With Cardiac Myxoma.心脏黏液瘤的超声心动图表现及临床相关性
JACC Cardiovasc Imaging. 2016 May;9(5):618-21. doi: 10.1016/j.jcmg.2015.04.029. Epub 2016 Feb 17.
7
Risk prediction for emboli and recurrence of primary cardiac myxomas after resection.原发性心脏黏液瘤切除术后栓子及复发的风险预测
J Cardiothorac Surg. 2016 Feb 2;11:22. doi: 10.1186/s13019-016-0420-4.
8
Stroke of a cardiac myxoma origin.心脏黏液瘤起源的中风。
Rev Bras Cir Cardiovasc. 2015 Mar-Apr;30(2):225-34. doi: 10.5935/1678-9741.20150022.
9
Platelets are dominant contributors to hypercoagulability after injury.血小板是损伤后高凝状态的主要贡献者。
J Trauma Acute Care Surg. 2013 Mar;74(3):756-62; discussion 762-5. doi: 10.1097/TA.0b013e3182826d7e.
10
Increased expression and activity of matrix metalloproteinases characterize embolic cardiac myxomas.基质金属蛋白酶表达增加及活性增强是栓塞性心脏黏液瘤的特征。
Am J Pathol. 2005 Jun;166(6):1619-28. doi: 10.1016/S0002-9440(10)62472-8.